Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Arch Neurol. 2010 Aug;67(8):949–956. doi: 10.1001/archneurol.2010.179

Figure 2.

Figure 2

Cerebrospinal fluid–derived β-amyloid protein 1–42 (CSF Aβ1–42) mixture model applied to the clinically diagnosed subject groups. AD indicates Alzheimer disease; MCI, mild cognitive impairment.